WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹407 Cr | ₹338 Cr | ₹298 Cr | ₹347 Cr | ₹284 Cr |
What is the latest Total Liabilities ratio of WANBURY ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹407 Cr |
| Mar2024 | ₹338 Cr |
| Mar2023 | ₹298 Cr |
| Mar2022 | ₹347 Cr |
| Mar2021 | ₹284 Cr |
How is Total Liabilities of WANBURY Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹407 Cr | 20.51 | |
| Mar2024 | ₹338 Cr | 13.29 | |
| Mar2023 | ₹298 Cr | -14.09 | |
| Mar2022 | ₹347 Cr | 22.35 | |
| Mar2021 | ₹284 Cr | - | |
Compare Total Liabilities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹730.1 Cr | 12.7% | -10.5% | -23% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 12.7% |
-10.5% |
-23% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses